CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 50 of 72 entries

View as:

A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3

Phase: N/A Priority: Normal

NCT ID: NCT00002106 Org: User:

Start: - End: - Due: -

A Study of 141W94 in Combination With Other Anti-HIV Drugs

Phase: N/A Priority: Normal

NCT ID: NCT00002372 Org: User:

Start: - End: - Due: -

A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases

Phase: N/A Priority: Normal

NCT ID: NCT00002044 Org: User:

Start: - End: - Due: -

Safety and Effectiveness of a Combination Anti-HIV Drug Treatment

Phase: N/A Priority: Normal

NCT ID: NCT00005018 Org: User:

Start: 07/31/99 End: 10/31/00 Due: 10/31/01

The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs

Phase: N/A Priority: Normal

NCT ID: NCT00002391 Org: User:

Start: - End: - Due: -

A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole

Phase: N/A Priority: Normal

NCT ID: NCT00001996 Org: User:

Start: - End: - Due: -

A Study of Amprenavir in HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002405 Org: User:

Start: - End: - Due: -

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection

Phase: N/A Priority: Normal

NCT ID: NCT00002183 Org: User:

Start: - End: - Due: -

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

Phase: N/A Priority: Normal

NCT ID: NCT00004852 Org: User:

Start: 09/30/99 End: - Due: -

A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems

Phase: N/A Priority: Normal

NCT ID: NCT00002315 Org: User:

Start: - End: - Due: -

An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine

Phase: N/A Priority: Normal

NCT ID: NCT00001990 Org: User:

Start: - End: - Due: -

A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002245 Org: User:

Start: 04/30/99 End: - Due: -

A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS

Phase: N/A Priority: Normal

NCT ID: NCT00002285 Org: User:

Start: - End: - Due: -

The Safety and Effectiveness of 524W91

Phase: N/A Priority: Normal

NCT ID: NCT00002335 Org: User:

Start: - End: - Due: -

A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002198 Org: User:

Start: - End: - Due: -

A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex

Phase: N/A Priority: Normal

NCT ID: NCT00002163 Org: User:

Start: - End: - Due: -

A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus

Phase: N/A Priority: Normal

NCT ID: NCT00002287 Org: User:

Start: - End: - Due: -

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

Phase: N/A Priority: Normal

NCT ID: NCT00002213 Org: User:

Start: - End: - Due: -

A Study of 1592U89 in HIV-Infected Children

Phase: N/A Priority: Normal

NCT ID: NCT00002197 Org: User:

Start: - End: - Due: -

The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT

Phase: N/A Priority: Normal

NCT ID: NCT00002436 Org: User:

Start: - End: - Due: -

The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002373 Org: User:

Start: - End: - Due: -

A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past

Phase: N/A Priority: Normal

NCT ID: NCT00002320 Org: User:

Start: - End: - Due: -

A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00005106 Org: User:

Start: 09/30/99 End: - Due: -

The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV Infection

Phase: N/A Priority: Normal

NCT ID: NCT00002290 Org: User:

Start: - End: - Due: -

The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease

Phase: N/A Priority: Normal

NCT ID: NCT00002001 Org: User:

Start: - End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3	NCT00002106	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of 141W94 in Combination With Other Anti-HIV Drugs	NCT00002372	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases	NCT00002044	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
Safety and Effectiveness of a Combination Anti-HIV Drug Treatment	NCT00005018	Glaxo Wellcome	user2@example.com	None	1999-07-31	2000-10-31	2001-10-31	-	-	2025-07-14
The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs	NCT00002391	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole	NCT00001996	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of Amprenavir in HIV-Infected Patients	NCT00002405	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection	NCT00002183	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs	NCT00004852	Glaxo Wellcome	user2@example.com	None	1999-09-30	-	-	-	-	2025-07-14
A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems	NCT00002315	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine	NCT00001990	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients	NCT00002245	Glaxo Wellcome	user2@example.com	None	1999-04-30	-	-	-	-	2025-07-14
A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS	NCT00002285	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
The Safety and Effectiveness of 524W91	NCT00002335	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients	NCT00002198	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex	NCT00002163	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus	NCT00002287	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors	NCT00002213	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of 1592U89 in HIV-Infected Children	NCT00002197	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT	NCT00002436	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients	NCT00002373	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past	NCT00002320	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients	NCT00005106	Glaxo Wellcome	user2@example.com	None	1999-09-30	-	-	-	-	2025-07-14
The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV Infection	NCT00002290	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease	NCT00002001	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance